ReP USP - Resultado da busca

Artigo de periodico
Naturally acquired humoral immunity against malaria parasites in non-human primates from the Brazilian Amazon, Cerrado and Atlantic Forest (2020)
Monteiro, Eliana Ferreira; Fernandez-Becerra, Carmen; Araújo, Maisa da Silva ; Messias, Mariluce Rezende; Ozaki, Luiz Shozo ; Duarte, Ana Maria Ribeiro de Castro; Bueno, Marina Galvão ; Catão-Dias, José Luiz ; Chagas, Carolina Romeiro Fernandes; Mathias, Bruno da Silva ; Santos, Mayra Gomes dos; Santos, Stéfanie Vanessa; Holcman, Marcia Moreira ; Souza Junior, Júlio César de; Kirchgatter, Karin
Source: Pathogens. Unidades: FMVZ, FM
Subjects: PRIMATAS, MALÁRIA DOS PRIMATAS NÃO HUMANOS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Eliana Ferreira et al. Naturally acquired humoral immunity against malaria parasites in non-human primates from the Brazilian Amazon, Cerrado and Atlantic Forest. Pathogens, v. 9, n. 7, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.3390/pathogens9070525. Acesso em: 10 nov. 2024.
APA
Monteiro, E. F., Fernandez-Becerra, C., Araújo, M. da S., Messias, M. R., Ozaki, L. S., Duarte, A. M. R. de C., et al. (2020). Naturally acquired humoral immunity against malaria parasites in non-human primates from the Brazilian Amazon, Cerrado and Atlantic Forest. Pathogens, 9( 7), 1-11. doi:10.3390/pathogens9070525
NLM
Monteiro EF, Fernandez-Becerra C, Araújo M da S, Messias MR, Ozaki LS, Duarte AMR de C, Bueno MG, Catão-Dias JL, Chagas CRF, Mathias B da S, Santos MG dos, Santos SV, Holcman MM, Souza Junior JC de, Kirchgatter K. Naturally acquired humoral immunity against malaria parasites in non-human primates from the Brazilian Amazon, Cerrado and Atlantic Forest [Internet]. Pathogens. 2020 ; 9( 7): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pathogens9070525
Vancouver
Monteiro EF, Fernandez-Becerra C, Araújo M da S, Messias MR, Ozaki LS, Duarte AMR de C, Bueno MG, Catão-Dias JL, Chagas CRF, Mathias B da S, Santos MG dos, Santos SV, Holcman MM, Souza Junior JC de, Kirchgatter K. Naturally acquired humoral immunity against malaria parasites in non-human primates from the Brazilian Amazon, Cerrado and Atlantic Forest [Internet]. Pathogens. 2020 ; 9( 7): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pathogens9070525
Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Source: Lancet. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 10 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Artigo de periodico
Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial (2016)
Kacmarek, Robert M.; Villar, Jesús; Sulemanji, Demet; Montiel, Raquel; Ferrando, Carlos; Blanco, Jesús; Koh, Younsuck; Soler, Juan Alfonso; Martínez, Domingo; Hernández, Marianela; Tucci, Mauro; Borges, Joao Batista; Lubillo, Santiago; Santos, Arnoldo; Araujo, Juan B.; Amato, Marcelo B. P.; Suárez-Sipmann, Fernando
Source: Critical Care Medicine. Unidade: FM
Subjects: ESTUDOS RANDOMIZADOS, TESTES RESPIRATÓRIOS, RESPIRADORES MECÂNICOS, SÍNDROME DO DESCONFORTO RESPIRATÓRIO EM ADULTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KACMAREK, Robert M. et al. Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial. Critical Care Medicine, v. 44, n. 1, p. 32-42, 2016Tradução . . Disponível em: https://doi.org/10.1097/CCM.0000000000001383. Acesso em: 10 nov. 2024.
APA
Kacmarek, R. M., Villar, J., Sulemanji, D., Montiel, R., Ferrando, C., Blanco, J., et al. (2016). Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial. Critical Care Medicine, 44( 1), 32-42. doi:10.1097/CCM.0000000000001383
NLM
Kacmarek RM, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J, Koh Y, Soler JA, Martínez D, Hernández M, Tucci M, Borges JB, Lubillo S, Santos A, Araujo JB, Amato MBP, Suárez-Sipmann F. Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial [Internet]. Critical Care Medicine. 2016 ; 44( 1): 32-42.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/CCM.0000000000001383
Vancouver
Kacmarek RM, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J, Koh Y, Soler JA, Martínez D, Hernández M, Tucci M, Borges JB, Lubillo S, Santos A, Araujo JB, Amato MBP, Suárez-Sipmann F. Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial [Internet]. Critical Care Medicine. 2016 ; 44( 1): 32-42.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/CCM.0000000000001383

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration